Sarecycline

Rosacea in Diverse Skin Tones | Recognition, Diagnosis, and Treatment
by Nishad Sathe, MD on
We have probably all seen a patient with rosacea. After all, it is quite common in middle-aged, fair-skinned women. Here, however, we will explore a talk given by Dr. Hilary Baldwin (Medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY, and Clinical Associate Professor of Dermatology at Rutgers Robert Wood Johnson Medical Center) at the 2022 Skin of Color …

Continue reading "Rosacea in Diverse Skin Tones | Recognition, Diagnosis, and Treatment"

Fifty Years of Minocycline and Its Evolution: A Dermatological Perspective
MINOCYCLINE
by NEXT STEPS IN DERM TEAM on
2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used prominently in acne vulgaris, and is also employed in many other dermatological conditions because of its molecular and pharmacological properties. In this article, we review the history of minocycli …

Continue reading "Fifty Years of Minocycline and Its Evolution: A Dermatological Perspective"

Special Focus on Acne and Rosacea
Acne and Rosacea
by NEXT STEPS IN DERM TEAM on
The June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist …

Continue reading "Special Focus on Acne and Rosacea"

Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline
Periorificial Dermatitis
by NEXT STEPS IN DERM TEAM on
Broad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic resistance and gut dysbiosis associated with broad spectrum tetracyclines emphasizes the importance and responsibility of antibiotic stewardship. Narrow spectrum antibiotics have become increasingly impo …

Continue reading "Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline"

From COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis
JDD April 2021 Issue
by NEXT STEPS IN DERM TEAM on
The April issue of the Journal of Drugs in Dermatology features the perfect mix of medical, aesthetic, and surgical dermatology articles on topics ranging from COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: A survey was designed to capture the incidence of adverse events in G …

Continue reading "From COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis"